On August 31st, the FDA rejected approximately 800 PMTAs for vaping products from three e-liquid manufacturers, on grounds that these failed to provide “product-specific scientific evidence to demonstrate enough of a benefit to adult smokers that would overcome the risk posed to youth.” The agency added that such evidence, “would likely be in the form […]

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email